SMTL ID : 6b30.2 (1 other biounit)

Structure of RORgt in complex with a novel inverse agonist 1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.69 Å

Oligo State

monomer

Ligands

1 x CFG: N-[(1R)-1-(4-methoxyphenyl)-2-oxo-2-{[4-(trimethylsilyl)phenyl]amino}ethyl]-N-methyl-3-oxo-2,3-dihydro-1,2-oxazole-5-carboxamide(Non-covalent)

CFG.1: 14 residues within 4Å: Chain A: Q.22, L.23, C.56, H.59, R.100, M.101, A.104, V.112, F.113, F.114, E.115, G.116, F.124, I.133 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.23, A:A.104, A:V.112, A:F.124 Hydrogen bonds: A:F.113, A:E.115 pi-Stacking: A:H.59, A:F.114

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shirai, J. et al., Discovery of orally efficacious ROR gamma t inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds. Bioorg. Med. Chem. (2018)

Release Date

2018-01-03

Peptides

Nuclear receptor ROR-gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence